Average Co-Inventor Count = 5.06
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Schering Aktiengesellschaft (12 from 1,384 patents)
2. Bayer Intellectual Property Gmbh (1 from 721 patents)
3. Novo Nordisk D/s (1 from 1 patent)
4. Bayer Schering Pharma Ag (192 patents)
13 patents:
1. 8445469 - 18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter
2. 7504410 - Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
3. 6958327 - 18 Norsteroids as selectively active estrogens
4. 6916921 - Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds
5. 6683197 - Process for the production of 4,4-dimethyl-5&agr;-cholesta-8,14,24-trien-3&bgr;-01 and intermediate products in process (I)
6. 6177416 - Oxyiminopregnancarbolactones
7. 6011060 - Chiral phenyldihydrofuranones as PDE-IV inhibitors
8. 5858394 - Agent for transdermal administration that contains gestodene esters
9. 5616573 - Glucocorticoids
10. 5529993 - 14.alpha., 17.alpha.-ethano-16.alpha.-hydroxy-estratrienes
11. 5439902 - 14.alpha., 16.alpha.-ethanoand 14.alpha., 16.alpha.-etheno-estratrienes
12. 4559331 - 7.alpha.-Substituted 3-oxo-17.alpha.-pregn-4-ene-21,17-carbolactones,
13. 4296109 - Corticoid 21-sulfopropionates and the salts thereof, a process for the